Challenges and approaches in developing an HIV vaccine through broadly neutralizing antibodies
By
James Binley
Summary
This article discusses the challenges and potential approaches to developing an effective HIV vaccine. It highlights that while therapies exist, they are limited by cost, infrastructure, and patient adherence. The key scientific approach explored is stimulating B cells to produce broadly neutralizing antibodies (bnAbs) against HIV. However, the diversity of the HIV envelope glycoprotein (Env) and its glycan shield make it difficult to generate bnAbs that can recognize all viral variants. The article references research involving rhesus macaques infected with a chimeric virus as a potential pathway to understanding how to elicit such antibodies.
Source
Twitter / XChallenges and approaches in developing an HIV vaccine through broadly neutralizing antibodiesscim.agKey quotes
· 5 pulledThe impact of therapies against HIV is limited by their cost, clinical infrastructure requirements, and patient adherence.
An effective vaccine could be a more cost-effective and practical solution to control the spread of HIV.
One approach to develop such a vaccine is to stimulate B cells of the immune system to produce broadly neutralizing antibodies (bnAbs) against the virus.
The diversity of the HIV envelope glycoprotein (Env) makes it difficult to generate bnAbs that can recognize all viral variants.
The shield of glycans (sugars) that forms the external surface of Env...
You might also wanna read
Vaccination elicits HIV broadly neutralizing antibodies in primates
Enhanced B cell priming induces broadly neutralizing HIV-1 apex antibodies
Phase 1 trial finds triple monoclonal antibody combination safe and effective for HIV-1 prevention
This phase 1, multicentre, randomised, open-label trial (HVTN 140/HPTN 101 part B) evaluated the safety, pharmacokinetics, and neutralisatio
Gene therapy shows promise for functional HIV cure in monkey study
A gene-therapy study published in Science Translational Medicine shows promise for a 'functional cure' for HIV. Researchers delivered a gene
science.org·20d ago
Engineered antibodies enhance complement-mediated immune clearance against drug-resistant bacterial infections
Researchers engineered monoclonal antibodies (mAbs) that bypass the initial steps of the classical complement activation pathway, enhancing
science.org·17d ago
Benchmarking Codon Optimization Strategies for Improved Antibody Expression
This article/webinar promotion discusses how antibody expression titers are critical for screening efficiency, developability, and manufactu
hubs.li·9d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.